Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.nebraska.edu

Clinical Trials

Cadaveric Islet Transplantation in Patients With Insulin-Dependent Diabetes Mellitus

Phase 1

Terminated

Conditions: Islets of Langerhans Transplantation
Diabetes Mellitus, Type 1

Interventions: Drug: Islets of Langerhans

First Posted Date: 2007-12-24

Last Posted Date: 2023-12-21

Lead Sponsor: University of Nebraska

Target Recruit Count: 30

Registration Number: NCT00579371

Locations: 🇺🇸
The Nebraska Medical Center, Omaha, Nebraska, United States

Comparison of Latanoprost Vs. Timolol

Phase 2

Terminated

Conditions: Glaucoma

Interventions: Drug: Latanoprost
Drug: Timolol

First Posted Date: 2007-12-24

Last Posted Date: 2023-12-21

Lead Sponsor: University of Nebraska

Target Recruit Count: 30

Registration Number: NCT00579969

Locations: 🇺🇸
UNMC Department of Ophthalmolgy and Visual Sciences, Omaha, Nebraska, United States

Treatment of Early RA: Minocycline in Combination With Methotrexate vs Methotrexate Alone

Phase 3

Completed

Conditions: Rheumatoid Arthritis

Interventions: Drug: Combination of Minocycline and MTX or MTX alone
Drug: methotrexate

First Posted Date: 2007-12-24

Last Posted Date: 2023-10-06

Lead Sponsor: University of Nebraska

Target Recruit Count: 91

Registration Number: NCT00579644

Locations: 🇺🇸
Unversity of Nebraska Medical Center, Omaha, Nebraska, United States

Reducing Blood Pressure in Prehypertensive Older Rural Women Also Known as Wellness for Women: DASHing Toward Health

Not Applicable

Completed

Conditions: Pre-Hypertension

Interventions: Behavioral: Tailored print newsletters delivered via mail
Behavioral: Tailored Internet Newsletters

First Posted Date: 2007-12-24

Last Posted Date: 2023-09-01

Lead Sponsor: University of Nebraska

Target Recruit Count: 289

Registration Number: NCT00580528

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants

Not Applicable

Completed

Conditions: Renal Insufficiency

Interventions: Drug: Zoledronic Acid
Combination Product: Calcium with vitamin D
Drug: Alendronate

First Posted Date: 2007-12-24

Last Posted Date: 2023-10-04

Lead Sponsor: University of Nebraska

Target Recruit Count: 59

Registration Number: NCT00580047

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Vascular Risk Progression in Normal and Diabetic Control Subjects.

Completed

Conditions: Diabetes
Inflammation

First Posted Date: 2007-12-24

Last Posted Date: 2023-09-14

Lead Sponsor: University of Nebraska

Target Recruit Count: 90

Registration Number: NCT00579228

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Detection of Coronary Stenosis With Intravenous Microbubbles

Not Applicable

Withdrawn

Conditions: Myocardial Reperfusion
Carotid Stenosis
Coronary Stenosis

Interventions: Drug: Optison
Drug: PESDA
Drug: Definity

First Posted Date: 2007-12-24

Last Posted Date: 2023-11-29

Lead Sponsor: University of Nebraska

Registration Number: NCT00580580

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Pre-operative Evaluation of Kidney & Pancreas Transplant Patients

Not Applicable

Completed

Conditions: Kidney Transplantation
Pancreas Transplantation

Interventions: Procedure: Dobutamine Stress Echocardiogram

First Posted Date: 2007-12-24

Last Posted Date: 2024-02-16

Lead Sponsor: University of Nebraska

Target Recruit Count: 150

Registration Number: NCT00580437

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis

Phase 3

Completed

Conditions: Rheumatoid Arthritis

Interventions: Drug: Methotrexate-Sulfasalazine-Hydroxychloroquine
Drug: Leflunomide-Sulfasalazine-Hydroxychloroquine
Drug: Leflunomide

First Posted Date: 2007-12-24

Last Posted Date: 2023-10-02

Lead Sponsor: University of Nebraska

Target Recruit Count: 69

Registration Number: NCT00579878

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate

Not Applicable

Terminated

Conditions: Nephropathy

Interventions: Drug: Oral N-Acetylcysteine
Drug: Sodium Bicarbonate

First Posted Date: 2007-12-24

Last Posted Date: 2023-09-21

Lead Sponsor: University of Nebraska

Target Recruit Count: 41

Registration Number: NCT00579995

Locations: 🇺🇸
Unversity of Nebraska Medical Center, Omaha, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy